![Alfredo Zurlo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alfredo Zurlo
No más puestos en curso
Perfil
Alfredo Zurlo served as Co-Managing Director at Glycotope GmbH.
He then worked as Chief Medical Officer at MOLOGEN AG from 2013 to 2016.
After that, he served as Chief Medical Officer at Scandion Oncology A.
Zurlo holds a doctorate degree from The American University of Rome.
Antiguos cargos conocidos de Alfredo Zurlo.
Empresas | Cargo | Fin |
---|---|---|
MOLOGEN AG | Director Técnico/Científico/I+D | 31/03/2016 |
SCANDION ONCOLOGY A/S | Director Técnico/Científico/I+D | - |
Glycotope GmbH
![]() Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Director Ejecutivo | - |
Formación de Alfredo Zurlo.
The American University of Rome | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
MOLOGEN AG | Commercial Services |
SCANDION ONCOLOGY A/S | Health Technology |
Empresas privadas | 1 |
---|---|
Glycotope GmbH
![]() Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Alfredo Zurlo